MOLECULAR DESIGN INTERNATIONAL, INC.

Company Information

Company Name
MOLECULAR DESIGN INTERNATIONAL, INC.
Address
111 South Highland Street
MEMPHIS, TN, 38111-
Phone
n/a
URL
n/a
DUNS
75592597
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$521,596.00
7
SBIR Phase II
$2,976,249.00
4
STTR Phase I
$208,399.00
2

Award List

  1. TOPICAL PRODRUGS FOR TREATMENT OF ACNE AND SKIN DISEASES

    Amount: $263,000.00

    THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DEVELOP A COMMERCIAL PRODUCT FOR THE TOPICAL TREATMENT OF ACNE AND SKIN DISEASES. THE SPECIFIC AIM OF THE PROPOSAL IS TO INVENT A PRODRUG THAT CAN BE USED ...

    SBIR Phase II 1987 Department of Health and Human Services
  2. TOPICAL PRODRUGS FOR THE TREATMENT OF PSORIASIS

    Amount: $500,000.00

    PSORIASIS IS A DISEASE THAT AFFECTS MILLIONS OF AMERICANS WITH CHRONIC RECURRENT EXACERBATIONS AND REMISSIONS THAT AREEMOTIONALLY AND PHYSICALLY DEBILITATING. SEVERAL TREATMENTSARE AVAILABLE, BUT IN M ...

    SBIR Phase II 1991 Department of Health and Human Services
  3. DEVELOPMENT OF ELASTASE INHIBITORS TO TREAT EMPHYSEMA

    Amount: $50,000.00

    THE GOAL OF THIS PROJECT IS TO DEVELOP A SYNTHETIC INHIBITOR OF ELASTASE THAT WILL BE EFFECTIVE AND SAFE IN THE TREATMENT OF EMPHYSEMA. TWO DIFFERENT LABORATORIES REPORTED THAT CHLOROMETHYL KETONE (CM ...

    SBIR Phase I 1991 Department of Health and Human Services
  4. Alpha Adrenergic Agonists for CPR

    Amount: $72,595.00

    In the United States alone, approximately 450,000 people yearly suffer a cardiac arrest outsidethe hospital. Less than 10% of these patients are discharged from the hospital alive, and of these,approx ...

    SBIR Phase I 1994 Department of Health and Human Services
  5. DEVELOPMENT OF MULTI-RECEPTOR LC STATIONARY PHASES

    Amount: $100,000.00

    DESCRIPTION: (Applicant's description) Combinatorial methods for the synthesis of new drug substances require high throughput techniques for evaluation of structure-activity relationshi ...

    STTR Phase I 2001 Department of Health and Human Services
  6. NON-IRRITATING RETINOIDS FOR THE TREATMENT OF AGING

    Amount: $99,000.00

    DESCRIPTION (provided by applicant): Molecular Design International, Inc. (MDI) has designed and synthesized three synthetic retinoids based on the removal of the free carboxylic acid proton and re ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. NON-IRRITATING RETINOIDS FOR THE TREATMENT OF AGING

    Amount: $1,016,500.00

    DESCRIPTION (provided by applicant): This application represents the Phase II version of SBIR grant R43 AR049621 entitled "Non-Irritating Retinoids for the Treatment of Aging Skin". Studies carried ou ...

    SBIR Phase II 2005 Department of Health and Human Services
  8. TOPICAL PRODRUGS FOR TREATMENT OF ACNE AND SKIN DISEASES

    Amount: $50,000.00

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  9. Wound Healing Properties of a Non-Irritating Novel 9-cis Retinoid Acid Derivative

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): MDI 301 is a synthetic retinoid that is similar to all-trans retinoic acid (RA) in its ability to stimulate collagen synthesis and inhibit the major collagen-degra ...

    SBIR Phase I 2006 Department of Health and Human Services
  10. TOPICAL PRODRUGS FOR THE TREATMENT OF PSORIASIS

    Amount: $50,000.00

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government